Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Degarelix dose-finding trial for LUTS associated with BPH
2009-012325-11Phase 2Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Aug 2009
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in benign prostatic hyperplasia (BPH) comparing Degarelix arm with Placebo arm (2 arms). Primary endpoint: Change in International Prostate Symptom Score (IPSS) at 3 months. Started Aug 2009; status: completed.
02
Drugs
degarelix
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on 2009-012325-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012325-11.